First, we didn't directly measure the baseline and post-treatment growth hormone levels of the NPC cases, thus we were unsure whether the reduced pituitary height was the true determinant of reduced growth hormone and stunted linear growth. This evidence concerns the gene GH1 and nasopharyngeal carcinoma.